文献速递骨肌介入CT

骨样骨瘤:经皮CT引导冷冻消融是成人安全、有效且持久的治疗选择

Osteoid Osteoma: Percutaneous CT-guided Cryoablation Is a Safe, Effective, and Durable Treatment Option in Adults.
PubMed 文献 · Radiology · 2021-11-23

本回顾性研究纳入50例连续接受经皮CT引导冷冻消融治疗的骨样骨瘤患者(中位年龄24岁),总体临床成功率为96%(48/50),中位VAS疼痛评分由术前8分降至术后0分(P < .001),3例(6%)出现轻微并发症,无严重并发症。作者结论认为CT引导经皮冷冻消融治疗骨样骨瘤安全、有效且持久,多数患者可在不使用全身麻醉的情况下完成治疗。

要点

  • 50例骨样骨瘤患者经皮CT引导冷冻消融总体临床成功率为96%(48/50)。
  • 中位VAS疼痛评分术前8分,术后6周及18-90个月随访均为0分(P < .001)。
  • 3例(6%)出现轻微并发症,无严重并发症报告。

核心结论

  • 作者结论认为,CT引导经皮冷冻消融治疗骨样骨瘤安全、有效且持久,多数患者可在不使用全身麻醉的情况下完成治疗,冷冻球可从骨外位置覆盖瘤巢。

研究设计与样本

  • 回顾性研究,纳入2013年1月至2019年6月单中心连续50例接受经皮CT引导冷冻消融治疗的骨样骨瘤患者(中位年龄24岁,四分位距19-38岁,男性31例)。
  • 50例中30例(60%)在局部麻醉加清醒镇静下完成操作,冷冻探针从骨外位置覆盖病变,避免直接穿入瘤巢。
  • 评估临床与影像学特征、操作相关数据、视觉模拟量表(VAS)疼痛评分、并发症及总体成功率;统计分析采用非参数Friedman检验和Wilcoxon符号秩检验用于重复测量。

诊断标准与关键数值

  • 总体临床成功率为96%(48/50);2例未获临床成功者中,1例疼痛缓解不完全,另1例在11个月时骨样骨瘤复发并经第二次冷冻消融成功治疗。
  • 中位VAS疼痛评分术前为8分(四分位距7-8),术后主要随访(6周)及次要随访(18-90个月)均为0分(四分位距0-1;P < .001)。
  • 50例中3例出现轻微并发症(6%),无严重并发症报告。

临床应用与阅片要点

  • 50例中30例(60%)在局部麻醉加清醒镇静下完成操作,冷冻探针从骨外位置覆盖病变,避免直接穿入瘤巢。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Cryoablation is playing an increasing role in the percutaneous treatment of bone tumors. However, despite its potential advantages over heat-based ablation techniques, the clinical safety and efficacy of cryoablation have not been established for osteoid osteoma treatment. Purpose To evaluate percutaneous CT-guided cryoablation for the treatment of osteoid osteoma in young patients and adults. Materials and Methods This retrospective study reviewed data from 50 consecutive patients who underwent percutaneous CT-guided cryoablation for the treatment of osteoid osteoma between January 2013 and June 2019 in a single institution. In 30 of 50 patients (60%), the procedure was carried out with the patient under local anesthesia and conscious sedation, with the cryoprobe covering the lesion from an extraosseous position, avoiding direct penetration of the nidus. Clinical and radiologic features, procedure-related data, visual analog scale (VAS) pain scores, complications, and overall success rate were evaluated. Statistical analyses were performed by using the nonparametric Friedman test and Wilcoxon signed rank test for repeated measures. Results Fifty patients (median age, 24 years; interquartile range [IQR], 19-38 years; 31 men) underwent CT-guided cryoablation for the treatment of osteoid osteoma, with a 96% (48 of 50 patients) overall clinical success rate. Of the two patients without clinical success, one patient had incomplete pain relief and the other experienced a recurrence of osteoid osteoma at 11 months, which was successfully treated with a second cryoablation procedure. The median VAS pain score was 8 (IQR, 7-8) before the procedure and 0 (IQR, 0-1; P < .001) after the procedure at both primary (6 weeks) and secondary (18-90 months) follow-up. Three of the 50 patients had minor complications (6%); no major complications were reported. Conclusion Osteoid osteoma was safely, effectively, and durably treated with CT-guided percutaneous cryoablation. In the majority of patients, treatment could be performed without general anesthesia, with the cryosphere covering the nidus from an extraosseous position. © RSNA, 2021.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Le Corroller, Vives, Mattei, et al. Osteoid Osteoma: Percutaneous CT-guided Cryoablation Is a Safe, Effective, and Durable Treatment Option in Adults. Radiology. 2021. PMID: 34812672. doi:10.1148/radiol.2021211100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。